日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial

保护接触新确诊的多重耐药结核病患者的家庭成员:PHEONIx 3期临床试验研究方案

Kendall, Michelle A; Hughes, Michael D; Kim, Soyeon; Aaron, Lisa A; Naini, Linda; Suryavanshi, Nishi; Shah, N Sarita; Rouzier, Vanessa; Hafkin, Jeffrey; Sise, Thucuma; Beck, Justine; Heckman, Barbara E; Haberer, Jessica E; Harrington, Mark; Scarsi, Kimberly K; Hesseling, Anneke C; Swindells, Susan; Churchyard, Gavin J; Gupta, Amita

Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis

拉替拉韦方案在4周至2岁感染人类免疫缺陷病毒并接受利福平治疗结核病的儿童中的药代动力学和安全性

Krogstad, Paul; Samson, Pearl; Acosta, Edward P; Moye, Jack; Townley, Ellen; Bradford, Sarah; Brown, Emily; Denson, Kayla; Graham, Bobbie; Hovind, Laura; Sise, Thucuma; Teppler, Hedy; Mathiba, Sisinyana Ruth; Fairlie, Lee; Winckler, Jana L; Slade, Gretchen; Meyers, Tammy